University of Helsinki
You can access the course material by clicking on the course title and typing the password that was provided to you via email.
All the courses will take place in Metsätalo. The course timetable and room locations can be found on the ULLA App (type the password that was provided to you via email).
AC: Analytical chemistry
AC -1 Electrospray-mass spectrometry based proteomics (Prof. Lisa Elviri) – CANCELED
AC-2 Vibrational spectroscopies and hyperspectral imaging: from theory to pharmaceutical and biomedical applications (Dr Ali Tfayli)
CP: Clinical pharmacy, pharmaceutical care and pharmacoeconomics
CP-1 Methodologies in Medication Safety and Effectiveness Research (Prof. Marja Airaksinen)
DD: Drug design and discovery
DD-1 Novel generation drugs and therapies starting from unique molecules found in the biodiversity of mother nature (Jan Tytgat)
DD-2 Protein X-ray Crystallography in Drug Design (Prof. Sergei Strelkov) (2 DAYS)
DD-3 NATURAL PRODUCTS AS LEADS IN DRUG RESEARCH: Dereplication, Lead Discovery and Innovation (John Nielsen) (2 DAYS)
DD-4 Engineering Nature’s Drug Factories (Dr Joleen Masschelein)
DD-5 Fighting antimicrobial resistance – Novel tools and concepts in antimicrobial drug discovery (Dr Päivi Tammela)
DD-7 Computer-Aided Drug Design (Alessio Lodola)
DD-8 Recent Advances in Cancer Drug Design (Abdallah Hamze)
DD-9 IDP-PROTEIN ASSOCIATION: MOLECULAR MODELING, BIOPHYSICS CHARACTERIZATION, AND INHIBITOR DESIGN (Tâp Ha-Duong and Sandrine Ongeri)
DD-10 Cancer Immunotherapy: the past the present and the future! (Vincenzo Cerullo) (2 DAYS)
DD-11 Prevention (and therapy) of cardiovascular disease in the post-statins era (Franco Bernini)
DD-12 Stereochemistry in Drug Synthesis and Development (Claudio Curti) (2 DAYS)
DD-13 Preclinical drug discovery in neuroscience (Timo Myöhänen)
DD-14 Workshop on Protein Structure Exploration in Drug Design and Discovery (Dr Shozeb Haider)
DD-15 Medicinal chemistry for non-chemists (Rasmus Prætorius Clausen and Lennart Bunch)
DT: Drug delivery and targeting
DT-1 Nanomedicines For Drug Delivery and Targeting Therapy (Hélder A. Santos)
DT-2 Drug-polymer interaction for macro-, micro- and nano- controlled oral delivery systems (Ruggero Bettini)
DT-3 Inhalation route for local and systemic delivery of biological drugs (Fabio Sonvico)
DT-4 Nanomedicine for skin and mucosal application (Silvia Pescina)
DT-5 Understanding Biological Barriers for Optimizing Drug Delivery (Gilles Ponchel)
DT-6 Formulation of protein pharmaceuticals (Marco van de Weert)
DT-7 Microfluidics for Pharmaceutical Applications: From Nano/Micro Systems Fabrication to Controlled Drug Delivery (Hélder A. Santos)
DT-8 Novel Drug Formulations for Tissue Regeneration (Mohammad-Ali Shahbazi and Mónica P. A. Ferreira)
DT-10 Drug transporters (Heidi Kidron)
EI: Environmental impact of pharmaceuticals
EI-1 Understanding the environmental footprint of drug development and use (Tiina Sikanen)
G: General skills
G-1 Phase IV clinical trials: Benefit and risk assessment of drugs in a real-world setting (Dr Li Wei)
G-2 Pharmaceutical policy and basic regulatory affairs (Lene Jørgensen)
G-3 Entrepreneurial skills for PhD students (Dr Mario Moustras)
PB: Pharmaceutical biotechnology
PB-1 Viral vectors and gene therapy: turning infectious viruses into a cure for genetic disorders (Prof. Rik Gijsbers)
PB-2 Biopharmaceuticals: From natural proteins to genetically and chemically modified derivatives (Stefano Bruno)
PB-3 Therapeutic Antibodies: From Bench to Clinic (Prof. Philippe Billiald)
PKPD: Pharmacokinetics, pharmacodynamics and drug safety
PKPD-1 Clinical Trial Simulations (Oscar Della Pasqua)
PKPD-2 Regenerative Pharmacology (Prof. Raimo K. Tuominen)
PKPD-3 Towards prediction of CNS drug distribution- blood-brain barrier transport and intrabrain distribution (Prof. Elizabeth de Lange)
PKPD-4 Introduction to PBPK (Ciaran Fisher, SIMCYP)
PT: Pharmaceutical technology
PT-1 Preformulation: physicochemical and biopharmaceutical profiling (Guy Van den Mooter)
PT-2 The iontophoretic approach: an innovative tool for drug delivery and non- invasive clinical monitoring (Patrizia Santi)
PT-3 Nanocrystals and amorphous formulation approaches – better solubility and bioavailability for brick dust drugs? (Leena Peltonen)
PT-4 Microfluidics in Pharmaceutical Sciences – from separation sciences and protein analysis to microphysiological models for drug delivery studies (Jörg P. Kutter)
PT-5 Quality by Design (QbD) in Drug Development (Prof. Jukka Rantanen)
PT-6 3D printing of pharmaceuticals (Prof. Jukka Rantanen)
PT-7 Biological evaluation of medical devices according to the European regulatory requirements (Dr Emile Jubeli)
PT-8 Physico-chemical tools – Understanding the active pharmaceutical ingredient (API) (Anette Müllertz, Christel Bergström, Thomas Rades)